PDF herunterladen
Thromb Haemost 2000; 84(06): 1122-1123
DOI: 10.1055/s-0037-1614184
Letters to the Editor
Schattauer GmbH

Anti-Xa Monitoring: Inter-assay Variability

F. Depasse
1   LCL, Ivry-sur-Seine, France
,
M. Gilbert
2   Serbio-Diagnostica Stago, Gennevil liers, France
,
V. Goret
2   Serbio-Diagnostica Stago, Gennevil liers, France
,
N. Rolland
2   Serbio-Diagnostica Stago, Gennevil liers, France
,
M. M. Samama
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Received 02. März 2000

Accepted after revision 24. Juli 2000

Publikationsdatum:
13. Dezember 2017 (online)

    Lizenzen und Reprints

 

 

  • References

  • 1 Kitchen S, Iampietro R, Wolley AM, Preston FE. Anti-Xa monitoring during treatment with low molecular weight heparin or danaparoid: inter-assay variability. Thromb Haemost 1999; 82: 1289-93.
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 2 Sié P, Aillaud MF, De Prost D, Droullé C, Forestier F, Guedj P, Juhan IVague, Polack B, Potron G, Roncato M, Roussi J, Sampol J, Aiach M. Measurement of low molecular weight heparin ex vivo activities in clinical laboratories using various anti-Xa assays: interlaboratory variability and requirement for an agreed low molecular weight heparin standard. Thromb Haemost 1987; 58: 879-83.
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 3 Abildgaard U, Norrheim L, Larsen AE, Nesvold A, Sandset PM, Õdegaard OR. Monitoring therapy with LM W heparin: a comparison of three chromo genic substrate assays and the Heptest clotting assay. Haemostasis 1990; 20: 193-203.
    PubMedGoogle Scholar
  • 4 Houbouyan L, Boutiere B, Contant G, Dautzenberg MD, Fievet P, Potron G, Vassault A, Gourmelin Y. Validation protocol of analytical hemostasis systems: measurement of anti-Xa activity of low-molecular-weight heparins. Clin Chem 1996; 42: 1223-30.
    PubMedGoogle Scholar